Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with mRNA ...
10don MSN
US FDA commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday ...
By Mariam Sunny March 2 (Reuters) - Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad, in response to a ...
Opinion
1hOpinion
We Lost the Lyme Vaccine. Under Rand Paul's New Vaccine Liability Bill, We'll Lose More.
The End the Vaccine Carveout Act would expose vaccine makers to lawsuits that once drove companies out of the industry.
September 2025: Dr. Marty Makary, now the FDA commissioner, claimed that the COVID vaccine killed children in an interview on CNN and promised a report would be released “in a few weeks.” No report is ...
Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at least 10 children," 12 former FDA commissioners released an extraordinary ...
A lawmaker compared getting the vaccine with using meth. The Idaho Medical Association said his bill would infringe on ...
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results